The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I does-escalation and expansion study of epidiolex (cannabidiol) in patients with biochemically recurrent prostate cancer.
 
Zin Myint
No Relationships to Disclose
 
William H. St.Clair
No Relationships to Disclose
 
Stephen Strup
No Relationships to Disclose
 
Peng Wang
No Relationships to Disclose
 
Andrew Callaway James
No Relationships to Disclose
 
Donglin Yan
No Relationships to Disclose
 
Carleton Scott Ellis
No Relationships to Disclose
 
Danielle E. Otto
No Relationships to Disclose
 
Robert S. DiPaola
No Relationships to Disclose
 
Susanne M. Arnold
Research Funding - AstraZeneca (Inst); Exelixis (Inst); Genentech (Inst); Kura Oncology (Inst); Merck Sharp & Dohme (Inst); National Cancer Institute (Inst); Nektar (Inst); Ohio State University (Inst); Regeneron (Inst)
 
Jill Kolesar
Stock and Other Ownership Interests - Helix Diagnostics
Consulting or Advisory Role - The Jackson Laboratory
Research Funding - ArtemiLife
Patents, Royalties, Other Intellectual Property - Patent pending for a cell based therapy derived from human macrophages